Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 110 entries
View as:

Study Evaluating Treatment Adherence in Patients Treated With Oral Targeted Therapy in Oncology Supported by a Dedicated and Coordinated Follow-up Compared to Standard Follow-up.

Phase: N/A Priority: Normal
NCT ID: NCT03263416 Org: User:
Start: 07/24/17 End: 01/25/22 Due: 01/25/23

Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2

Phase: N/A Priority: Normal
NCT ID: NCT05427461 Org: User:
Start: 01/13/23 End: 07/31/26 Due: 07/31/27

E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT04228432 Org: User:
Start: 02/28/20 End: 07/21/21 Due: 07/21/22

Evaluation of the Adhesion to the GENEPY Network

Phase: N/A Priority: Normal
NCT ID: NCT03979612 Org: User:
Start: 08/01/19 End: 12/31/20 Due: 12/31/21

Impact of Circadian Rhythm on the Spread of Circulating Tumor Cells in Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05988970 Org: User:
Start: 01/29/24 End: 09/30/25 Due: 09/30/26

Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas

Phase: N/A Priority: Normal
NCT ID: NCT06557889 Org: User:
Start: 10/21/24 End: 09/30/30 Due: 09/30/31

Evaluation of Pain and Postoperative Nausea Vomiting Incidence in Outpatient Surgery at IUCT-Oncopole Hospital

Phase: N/A Priority: Normal
NCT ID: NCT03669328 Org: User:
Start: 06/01/16 End: 06/30/18 Due: 06/30/19

PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05581121 Org: User:
Start: 12/20/23 End: 12/31/33 Due: 12/31/34

Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05378204 Org: User:
Start: 06/23/22 End: 06/30/27 Due: 06/30/28

Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04515459 Org: User:
Start: 09/13/22 End: 11/30/27 Due: 11/30/28

Pharmacology of Adjuvant Hormonotherapy in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01127295 Org: User:
Start: 06/17/10 End: 12/01/17 Due: 12/01/18

Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome

Phase: N/A Priority: Normal
NCT ID: NCT06917781 Org: User:
Start: 05/31/25 End: 08/31/28 Due: 08/31/29

The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.

Phase: N/A Priority: Normal
NCT ID: NCT03619044 Org: User:
Start: 08/28/20 End: 07/09/21 Due: 07/09/22

Evaluation of the Impact of a Follow-up Phone Call Nurse Device in the Care of Patients With Chemotherapy Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02619045 Org: User:
Start: 11/09/15 End: 06/21/17 Due: 06/21/18

Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

Phase: N/A Priority: Normal
NCT ID: NCT05983991 Org: User:
Start: 12/07/23 End: 12/31/33 Due: 12/31/34

Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC

Phase: N/A Priority: Normal
NCT ID: NCT04368468 Org: User:
Start: 06/15/20 End: 01/31/21 Due: 01/31/22

Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00801151 Org: User:
Start: 01/31/09 End: 11/30/09 Due: 11/30/10

Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT03514381 Org: User:
Start: 05/18/18 End: 11/23/20 Due: 11/23/21

Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.

Phase: N/A Priority: Normal
NCT ID: NCT01902680 Org: User:
Start: 08/23/13 End: 06/06/17 Due: 06/06/18

TNF in Melanoma Patients Treated With Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03348891 Org: User:
Start: 09/05/18 End: 11/22/21 Due: 11/22/22

Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03956459 Org: User:
Start: 07/25/19 End: 02/04/21 Due: 02/04/22

Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage

Phase: N/A Priority: Normal
NCT ID: NCT00224744 Org: User:
Start: 11/30/05 End: 01/31/13 Due: 01/31/14

Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.

Phase: N/A Priority: Normal
NCT ID: NCT00268125 Org: User:
Start: 02/28/06 End: 12/31/07 Due: 12/31/08

Accompaniment of Patients by Dental Assistants in the Evaluation of Oral Hygiene During and After Radiotherapy Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT05494970 Org: User:
Start: 10/13/22 End: 01/30/24 Due: 01/30/25

Platino-resistance in Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03954171 Org: User:
Start: 03/06/20 End: 03/31/30 Due: 03/31/31